home / stock / bhc:cc / bhc:cc news


BHC:CC News and Press, Bausch Health Companies Inc. From 07/09/25

Stock Information

Company Name: Bausch Health Companies Inc.
Stock Symbol: BHC:CC
Market: TSXC
Website: bauschhealth.com

Menu

BHC:CC BHC:CC Quote BHC:CC Short BHC:CC News BHC:CC Articles BHC:CC Message Board
Get BHC:CC Alerts

News, Short Squeeze, Breakout and More Instantly...

BHC:CC - Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans of Ontario, Quebec and Two Federal Programs

LAVAL, QC / ACCESS Newswire / July 9, 2025 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that Pr CABTREO TM (clindamycin phosphate, adapalene and benzoyl peroxide) gel 1.2% w/w, 0.15% w/w and 3.1% w/w, for the treatment of acne vulgar...

BHC:CC - Bausch Health's Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh "I Wish I Knew" Campaign to Educate People About Xifaxan(R) (rifaximin) for Adults at Risk of Overt Hepatic Encephalopathy Recurrence

Focused on highlighting real patient experiences, Salix continues to lead the charge in educating and advocating for the hepatic encephalopathy community LAVAL, QC / ACCESS Newswire / July 7, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, S...

BHC:CC - Bausch Health to Announce Second Quarter 2025 Results on July 30

LAVAL, QC / ACCESS Newswire / July 2, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release second quarter 2025 financial results after market close on Wednesday, July 30, 2025. Bausch Health will host a conference call and live webcast at 5:00 p.m. U.S. EDT to discuss the resul...

BHC:CC - NYLI MacKay High Yield Corporate Bond Fund Q1 2025 Commentary

2025-07-01 06:21:00 ET Market Review High Yield posts positive returns despite March volatility The ICE BofA U.S. High Yield Index declined 1.07% in March, brining first quarter returns to 0.94%. Yields and spreads moved in lockstep for most of the year until late February...

BHC:CC - Thrivent High Yield Fund Q1 2025 Commentary

2025-06-30 00:30:00 ET Performance factors Tariffs took the spotlight during the first quarter creating significant uncertainty regarding inflation prospects and economic growth. This uncertainty led spreads (the additional yield over risk-free Treasuries) to increase sixty basis po...

BHC:CC - Insider trades: Broadcom, Dell among notable names this week

2025-06-21 11:03:00 ET This week’s insider trading summary highlights significant buying and selling activity by company insiders, including investors, executives, and board members across several technology firms like Broadcom ( NASDAQ: AVGO ) and Dell Technologies ( NYSE:...

BHC:CC - Markets Shuttered for "Juneteenth"

U.S. markets are closed Thursday for the “Juneteenth” holiday.

BHC:CC - Stocks Rise Ahead of Fed Decision

U.S. stocks rose on Wednesday as traders monitor the latest developments in the Middle East and brace for the Federal Reserve’s latest rate policy decision. The Dow Jones Industrials soared 175.89 points as Wednesday morning became afternoon at 42,391.69. The S&P 500 index pick...

BHC:CC - Repricing Potential Driven By Deleveraging

2025-06-16 04:04:44 ET ... Read the full article on Seeking Alpha For further details see: Repricing Potential Driven By Deleveraging

BHC:CC - Bausch Health ticks higher following large director stock purchase

2025-06-13 09:23:17 ET More on Bausch Health Companies Bausch Health Companies Inc. (BHC) Q1 2025 Earnings Call Transcript Bausch Health Companies Inc. 2025 Q1 - Results - Earnings Call Presentation Bausch Health: Repositioning Aplezin As First Oral Monotherapy For T...

Previous 10 Next 10